Ospedale Ruber Internacional
La dottoressa è un chirurgo oncologico specializzato in carcinosi peritoneale e fa parte del Gruppo Chirurgico di Carcinosi dell'Istituto Oncologico Teknon dal 2019. Ha completato la sua specializzazione al Washington Hospital Center sotto la guida del Prof. Paul Sugarbaker e possiede la certificazione dell'American Board of Surgery.<\/p>
È membro di diverse società prestigiose, tra cui l'American College of Surgeons e la Society of Surgical Oncology. I suoi ruoli accademici hanno incluso il Direttore della Ricerca presso l'Inova Fairfax Hospital e posizioni di Professore Associato presso la Virginia Commonwealth University e la Georgetown University.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Il medico è responsabile della gestione delle malignità toraciche e supervisiona le sperimentazioni sul cancro toracico presso il Dipartimento di Oncologia. La loro ricerca si concentra sull'ottimizzazione della chemioterapia nelle fasi iniziali della malattia, sulla valutazione di nuove terapie, sull'esplorazione di approcci farmacogenomici, sull'integrazione dell'immunoterapia per il cancro ai polmoni e sull'indagine dei meccanismi di resistenza agli inibitori della tirosina-chinasi.<\/p>
Con una laurea in medicina e un dottorato in oncologia medica presso l'UAB, il medico è membro di diverse società oncologiche prestigiose, tra cui ESMO, ASCO e IASLC. Hanno pubblicato numerosi articoli sottoposti a revisione paritaria e capitoli di libri sulle malignità toraciche e hanno ricoperto posizioni di insegnamento presso l'UAB e UVicc-UCC.<\/p>
Medical Director of the University of Navarra Clinic
Prof. of hematology and hemotherapy
Spanish medical protocols for thymoma involve multidisciplinary planning by surgeons and oncologists. Treatment typically includes extended thymectomy for early stages or multimodal therapy for advanced cases. JCI-accredited centers in Madrid and Barcelona utilize robotic surgery and platinum-based chemotherapy following European Society for Medical Oncology standards.
Bookimed Expert Insight: Spain ranks 7th globally in our network for complex oncology requests. Data shows centers like Clinica Universidad de Navarra maintain high quality as the first JCI-certified hospital in Spain. Patients should prioritize clinics with integrated thoracic departments. For instance, Hospital Quiron Barcelona houses the Baselga Institute of Oncology, which specializes in rare tumor protocols like thymoma.
Patient Consensus: Patients emphasize finding a center with specific thoracic expertise rather than general hospitals. They note it is essential to discuss how existing conditions like myasthenia gravis affect anesthesia safety.
Spanish medical centers provide advanced minimally invasive thymoma surgery using Robot-Assisted Thoracic Surgery (RATS) and Video-Assisted Thoracic Surgery (VATS). These techniques allow surgeons to remove the thymus gland through small keyhole incisions. They preserve the breastbone and significantly accelerate postoperative recovery.
Bookimed Expert Insight: Spain presents a high concentration of JCI-accredited centers like Centro Médico Teknon and Clínica Universidad de Navarra. Data indicates these facilities prioritize high-volume surgical expertise, with some performing over 23,000 operations annually. Patients should select clinics with dedicated robotic units, as these centers often report shorter hospital stays of 1–3 days.
Patient Consensus: Patients value the smaller cosmetic scars and reduced pain compared to traditional open surgery. Many suggest confirming the surgeon's specific experience with robotic thymectomy to ensure the most precise outcome.
Spanish hospitals offer proton therapy for advanced or recurrent thymoma at specialized oncology centers in Madrid and Pamplona. These facilities use precision proton beams to treat mediastinal tumors near the heart and lungs. This technology is essential for re-irradiation when tumors recur in previously treated areas.
Bookimed Expert Insight: While several Spanish centers like Clinica Universidad de Navarra and Quironsalud are JCI-accredited, they serve different patient volumes. Clinica Universidad de Navarra treats over 140,000 patients annually and was the first in Spain to receive US JCI certification. Patients should prioritize centers with large-scale oncology frameworks. These institutions often provide integrated access to clinical trials and multi-specialty thoracic boards for complex recurrences.
Patient Consensus: Patients note that proton therapy is significantly easier to tolerate than conventional radiation. They often emphasize the importance of having a thoracic tumor board review their specific case first.
Spain manages post-operative monitoring through standardized protocols spanning 10 to 15 years. Specialist-led teams at centers like Clinica Universidad de Navarra use CT surveillance to track recurrences. Multidisciplinary boards coordinate care for associated conditions like myasthenia gravis to ensure long-term patient safety.
Bookimed Expert Insight: Spanish oncology centers like Hospital HM Nou Delfos and Hospital Quiron Barcelona integrate advanced imaging directly into follow-up. While many expect general check-ups, Spain’s high global rank in oncology is driven by technology-heavy monitoring. This includes PET-CT and MRI to detect microscopic changes long before symptoms appear.
Patient Consensus: Patients note that surgery is only the first step. Many emphasize keeping personal files of pathology and operative reports to coordinate care between surgeons and oncologists during years of follow-up scans.
Spain offers high-level thymoma care at accredited centers like Centro Medico Teknon and Quironsalud Madrid. These facilities utilize multidisciplinary tumor boards and advanced thoracic surgery. Specialized oncology platforms ensure precise management of rare mediastinal tumors within JCI-accredited environments in Barcelona and Madrid.
Bookimed Expert Insight: Data shows that hospital volume is a critical quality indicator in Spain. For instance, Centro Medico Teknon manages 10,000 patients annually. Large networks like HM Hospitales serve over 2,000,000 outpatients. Choosing these high-volume hubs ensures access to surgeons who perform complex mediastinal resections regularly. This experience is vital for managing rare cases like thymoma effectively.
Patient Consensus: Patients note it's important to find a thoracic surgeon who handles mediastinal masses frequently. Many emphasize getting a second pathology review to confirm the exact thymoma subtype before starting treatment.